ArticleJSES international2026
Perioperative outcomes following tranexamic acid use in arthroscopic rotator cuff repair.
Article in JSES international, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Tranexamic acid (TXA) is widely used in orthopedic surgery to mitigate intraoperative and post-operative bleeding. Current literature supports its use in arthroscopic rotator cuff repair (RCR) to increase visualization, decrease operative time, and improve immediate post-operative pain. This study aimed to assess post-operative outcomes of arthroscopic RCR with and without perioperative TXA. We hypothesize that TXA use will result in decreased post-operative complications, including less pain and therefore fewer opioid prescriptions. Methods: The TriNetX database was queried to assess post-operative outcomes after arthroscopic RCR with and without perioperative TXA performed between January 1, 2010, and December 31, 2024. Post-operative outcomes were evaluated at one month and followed for one year. Evaluated outcomes included emergency department visits, hospital admissions, superficial and deep surgical site infections, pulmonary embolism, and number of opioid prescriptions. One-to-one greedy propensity score matching was performed to control for potential confounding variables, and odds ratios were calculated to assess the overall risk of the outcomes of interest between cohorts. A Results: We identified 120,236 RCR without perioperative TXA and 7,645 RCR with perioperative TXA. After matching based on demographics and medical comorbidities, 7,645 patients remained in each cohort. Analysis at both 1 month and 1 year post-operative demonstrated that patients receiving perioperative TXA were associated with fewer opioid prescriptions (27.9% versus 31.2% at 30 days and 43.5% versus 47.2% at 1 year, Conclusion: This is the first large-scale, database study demonstrating perioperative TXA in the setting of arthroscopic RCR was associated with significantly improved post-operative outcomes, particularly fewer post-operative opioid prescriptions at 30 days and 1 year and a decrease in hospital admissions at 1-year follow-up. This updates the limited current literature surrounding TXA use during shoulder arthroscopy, with some studies suggesting improved visual field and decreased immediate post-operative pain, while others positing no clinical difference in pain reduction. Future well-designed prospective studies are needed to elucidate these associations more fully.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.